Therapy Areas: Inflammatory Diseases
Humanetics Expands Long-Haul COVID-19 Trial
19 May 2022 - - US-based clinical-stage pharmaceutical company Humanetics Corp has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated fo...
The Janssen Pharmaceutical Companies presents new TREMFYA(R) (guselkumab) data
19 May 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced on Wednesday the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the...
AbbVie and Cugene to collaborate on autoimmune diseases
17 May 2022 - US-based biopharmaceutical company AbbVie (NYSE: ABBV) and Cugene Inc., a US-based clinical-stage biotechnology company focused on developing next-generation precision immunology and onc...
AbbVie to present gastroenterology portfolio and pipeline at Digestive Disease Week(R)
17 May 2022 - US-based biopharmaceutical company AbbVie (NYSE: ABBV) announced on Monday that 27 abstracts across its gastroenterology portfolio will be presented at the Digestive Disease Week (DDW) A...
Avacta announces expansion of AffyXell's manufacturing partnership with GenScript ProBio for cell therapies
16 May 2022 - Clinical stage oncology drug company Avacta Group plc (AIM:AVCT) reported on Monday that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded it...
Nuvig Launches to Develop Novel Immune Therapeutics for Chronic Inflammatory and Autoimmune Diseases
...
Related Headlines

AbbVie's upadacitinib (RINVOQ(R)) Achieved Clinical Remission and Endoscopic Response at One Year in Phase 3 Maintenance Study in Patients with Crohn's Disease

Glyscend Therapeutics Completes Phase 1 Clinical Trial of its Oral, Gut-restricted, Polymer Therapeutic, GLY-200, as a Potential Type 2 Diabetes Treatment

TikoMed AB enters into strategic collaboration with IQVIA

Iveric Bio Presents Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura in Patients with Geographic Atrophy

International Pregistry Study Examines Treatments Used for COVID-19 During Pregnancy

Santen's Verkazia 0.1% Now Available for the Treatment of Vernal Keratoconjunctivitis in Children and Adults in the United States

Horizon Therapeutics Receives European Commission Approval of Uplizna for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder

Gilead, Dragonfly Forge Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation

AbbVie receives FDA for RINVOQ to treat adults with active ankylosing spondylitis

Valbiotis Announces the First Visit of the First Patient in the TOTUM•63 Mode of Action Clinical Study Conducted by the INAF1, in Partnership with Nestlé Health Science

Aruna Bio names new chief executive officer

Quanterix Granted Breakthrough Device Designation from US FDA for NfL Test for Multiple Sclerosis

Samsara Vision to Initiate a US PMA Supplemental Study of the SING IMT, a New-Generation Technology for Age-Related Macular Degeneration

Neuromyelitis Optica Linked to Antibody Exposure During Fetal Development, Feinstein Institutes Study Finds

INRAE and MaaT Pharma Build on Long-Standing Partnership with the Entry of Drug-Candidate MaaT013 into Phase 3 Clinical Trial